Citigroup »

Trevi Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.3k 7.0k 1.34
2023-09-30 $93 43 2.18

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
Viking Global Investors
VR Adviser
Opaleye Management
Vanguard Group
Checkpoint Capital
MAI Wealth Advisors
Tejara Capital
Rosalind Advisors
Landscape Capital Management
Tang Capital Management
Citadel Advisors
J. Goldman & Co
Bank of New York Mellon

View all funds holding Trevi Therapeutics